Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety in patients with multiple myeloma: a step forward personalised medicine (Q3183561): Difference between revisions
Jump to navigation
Jump to search
(Set a claim value: summary (P836): Aplicação da farmacogenómica para aumentar a utilização de biomarcadores para o efeito do medicamento e a segurança do medicamento em doentes com mieloma múltiplo: um passo em frente na medicina personalizada) |
(Changed label, description and/or aliases in pt) |
||
| label / pt | label / pt | ||
Aplicação | Aplicação da farmacogenómica para aumentar a utilização de biomarcadores para o efeito do medicamento e a segurança do medicamento em doentes com mieloma múltiplo: um passo em frente na medicina personalizada | ||
Latest revision as of 09:56, 10 October 2024
Project Q3183561 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety in patients with multiple myeloma: a step forward personalised medicine |
Project Q3183561 in Spain |
Statements
66,156.75 Euro
0 references
121,500.0 Euro
0 references
54.45 percent
0 references
1 January 2014
0 references
31 July 2017
0 references
HOSPITAL UNIVERSITARIO DE SALAMANCA
0 references
Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety in patients with multiple myeloma: a step forward personalized medicine (Spanish)
0 references
Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety in patients with multiple myeloma: a step forward personalised medicine (English)
12 October 2021
0.0469932973501916
0 references
Application de la pharmacogénomique pour améliorer l’utilisation de biomarqueurs pour l’effet médicamenteux et l’innocuité des médicaments chez les patients atteints de myélome multiple: un pas en avant en médecine personnalisée (French)
4 December 2021
0 references
Anwendung der Pharmakogenomics zur Verbesserung der Verwendung von Biomarkern für die Arzneimittelwirkung und die Arzneimittelsicherheit bei Patienten mit multiplem Myelom: ein Schritt nach vorn personalisierte Medizin (German)
9 December 2021
0 references
Het toepassen van farmacogenomica om het gebruik van biomarkers voor geneesmiddeleffect en geneesmiddelveiligheid te verbeteren bij patiënten met multipel myeloom: een stap voorwaarts gepersonaliseerde geneeskunde (Dutch)
17 December 2021
0 references
Applicazione della farmacogenomica per migliorare l'uso di biomarcatori per l'effetto farmacologico e la sicurezza del farmaco in pazienti con mieloma multiplo: un passo avanti nella medicina personalizzata (Italian)
16 January 2022
0 references
Farmakogenoomika rakendamine, et suurendada ravimi toime ja ravimi ohutuse biomarkerite kasutamist hulgimüeloomiga patsientidel: samm edasi personaliseeritud meditsiin (Estonian)
4 August 2022
0 references
Farmakogenomikos taikymas siekiant padidinti biologinių žymenų naudojimą vaistų poveikiui ir vaistų saugumui daugine mieloma sergantiems pacientams: žingsnis į priekį individualizuotos medicinos (Lithuanian)
4 August 2022
0 references
Primjena farmakogenomike za poboljšanje uporabe biomarkera za učinak lijeka i sigurnost lijekova u bolesnika s multiplim mijelomom: korak naprijed personalizirana medicina (Croatian)
4 August 2022
0 references
Εφαρμογή φαρμακογονιδιωματικής για την ενίσχυση της χρήσης βιοδεικτών για την επίδραση του φαρμάκου και την ασφάλεια των φαρμάκων σε ασθενείς με πολλαπλό μυέλωμα: ένα βήμα προς τα εμπρός εξατομικευμένη ιατρική (Greek)
4 August 2022
0 references
Použitie farmakogenomiky na zlepšenie používania biomarkerov pre účinok lieku a bezpečnosť liekov u pacientov s mnohopočetným myelómom: krok vpred personalizovaná medicína (Slovak)
4 August 2022
0 references
Farmakogenomiikan soveltaminen biomarkkerien käytön tehostamiseksi lääkevaikutuksiin ja lääketurvallisuuteen multippelia myeloomaa sairastavilla potilailla: askel eteenpäin henkilökohtainen lääketiede (Finnish)
4 August 2022
0 references
Stosowanie farmakogenomiki w celu zwiększenia stosowania biomarkerów do działania leku i bezpieczeństwa stosowania leku u pacjentów ze szpiczakiem mnogim: krok naprzód spersonalizowana medycyna (Polish)
4 August 2022
0 references
Farmakogenomika alkalmazása a mielóma multiplexben szenvedő betegeknél a gyógyszerhatást és a gyógyszerbiztonságot szolgáló biomarkerek használatának fokozására: lépés a személyre szabott orvoslás felé (Hungarian)
4 August 2022
0 references
Použití farmakogenomiky ke zlepšení používání biomarkerů pro účinek léčiv a bezpečnost léčiv u pacientů s mnohočetným myelomem: krok vpřed personalizovaná medicína (Czech)
4 August 2022
0 references
Farmakoloģiskie līdzekļi, lai uzlabotu biomarķieru lietošanu zāļu iedarbībai un zāļu drošumam pacientiem ar multiplo mielomu: solis uz personalizētu medicīnu (Latvian)
4 August 2022
0 references
Iarratas a dhéanamh ar pharmacogenomics chun feabhas a chur ar úsáid bithmharcóirí le haghaidh éifeacht drugaí agus sábháilteacht drugaí in othair a bhfuil myeloma iolrach: céim chun cinn leigheas pearsantaithe (Irish)
4 August 2022
0 references
Uporaba farmakogenomike za povečanje uporabe biomarkerjev za učinek zdravila in varnost zdravil pri bolnikih z diseminiranim plazmocitomom: korak naprej personalizirana medicina (Slovenian)
4 August 2022
0 references
Прилагане на фармакогеномика за подобряване на употребата на биомаркери за лекарствен ефект и лекарствена безопасност при пациенти с множествен миелом: стъпка напред персонализирана медицина (Bulgarian)
4 August 2022
0 references
Applikazzjoni ta’ farmakoġenomika biex ittejjeb l-użu ta’ bijomarkaturi għall-effett tal-mediċina u s-sigurtà tal-mediċina f’pazjenti b’majeloma multipla: pass’il quddiem tal-mediċina personalizzata (Maltese)
4 August 2022
0 references
Aplicação da farmacogenómica para aumentar a utilização de biomarcadores para o efeito do medicamento e a segurança do medicamento em doentes com mieloma múltiplo: um passo em frente na medicina personalizada (Portuguese)
4 August 2022
0 references
Anvendelse af farmakogenomik for at øge brugen af biomarkører for lægemiddeleffekt og lægemiddelsikkerhed hos patienter med multipelt myelomatose: et skridt fremad personlig medicin (Danish)
4 August 2022
0 references
Aplicarea farmacogenomicii pentru a spori utilizarea biomarkerilor pentru efectul medicamentos și siguranța medicamentelor la pacienții cu mielom multiplu: un pas înainte medicina personalizată (Romanian)
4 August 2022
0 references
Tillämpa farmakogenomik för att öka användningen av biomarkörer för läkemedelseffekt och läkemedelssäkerhet hos patienter med multipelt myelom: ett steg framåt individanpassad medicin (Swedish)
4 August 2022
0 references
Salamanca
0 references
20 December 2023
0 references
Identifiers
CP13_00080
0 references